Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 12/2/2024Everest Medicines Announces Acceptance of VELSIPITY NDA in Hong Kong
  • 11/29/2024Recent Executive Moves
  • 11/28/2024AstraZeneca's Enhertu Secures Reimbursement Listing Despite Ongoing Pr...
  • 11/28/2024BeOne Secures EU Approval for First-Line Checkpoint Blocker
  • 11/28/2024NMPA Solicits Public Comments on the Provisions for the Record Filing ...
  • 11/28/2024NHSA and MOHRSS Announce the 2024 National Drug Reimbursement List
  • 11/28/2024NHSA Issues Guidelines for Managing Pricing Risks of Shortage Drugs
  • 11/27/2024China Introduces New Policy to Strengthen Hierarchical Medical Care an...
  • 11/27/2024NHSA: Policies in Development to Synchronize Medical Insurance Funds a...
  • 11/27/2024Policy Change Set to Advance Cell and Gene Therapy in China
  • 11/27/2024CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China
  • 11/27/2024NMPA Accepts Akeso's sNDA for Penpulimab Plus Anlotinib for Advanced H...
  • 11/27/2024Hengrui Initiates Clinical Trial for SHR-1826, a c-Met ADC Drug
  • 11/27/2024Kelun's Merck-partnered TROP2 ADC sac-TMT Approved for Marketing in C...
  • 11/27/2024ChP Commission Approves Chinese Pharmacopeia 2025
  • 11/26/2024Snapshot of BMI System Financial Performance in 3Qs/2024
  • 11/25/2024China's Real-World Data Pilot Drives Global Collaboration and Regulato...
  • 11/25/2024DP Tech and Lepu Biopharma Enter ADC Partnership
  • 11/25/2024Rui Thera Present Clinical Trial Results of CD19 CAR NK Cell Therapy i...
  • 11/25/2024BRL Medicine Secures ~CNY 200M in Series B+ Financing to Advance Gene ...
  • 11/25/2024TG ImmunoPharma Completes Series Pre-A+ Financing to Accelerate Immuno...
  • 11/25/2024Junshi Secures Licensing Deal for Bispecific Fusion Proteins
  • 11/25/2024Zhongsheng Announces Promising Phase II Results for Weight Loss Drug R...
  • 11/25/2024Hanx Biopharma Submits IPO Application to HKSE
  • 11/25/2024Kanglin Biotech Announces $20M Series A Financing to Advance Gene Ther...
  • 11/22/2024Recent Executive Moves
  • 11/22/2024NHC Issues the Opinions on Reforming and Improving the Grassroots Drug...
  • 11/22/2024Hua Medicine to Terminate China Commercialization Agreement with Bayer...
  • 11/21/2024Sino Biopharma Strengthens Oncology Portfolio with Investment in LaNov...
  • 11/21/2024China Strengthens Focus on Gene and Cell Therapy Research in Suzhou
  • Page:21/47 Total number of articles:1389: [First][<<] [19] [20] [21] [22] [23] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group